Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 22:06 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery
NCT01422148 · Baystate Medical Center · PHASE2 · withdrawn · last registry update 2026-09-30 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “NOT ENOUGH PARTICIPANTS” | – | Registry record, Baystate Medical Center |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against KCNH2 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-11-05Results posted on the registry: WakeMed Health and Hospitals, CardiaMend with the Addition of Amiodarone (NCT05681182)
- 2026-11-03Also stopped (withdrawn): Hellenic Institute for the Study of Sepsis, Metformin + Placebo (NCT04177303)
- 2026-10-28Results posted on the registry: King's College London, Metformin + Ursodeoxycholic Acid (NCT04407650)
- 2026-10-28Also stopped (terminated): King's College London, Metformin + Ursodeoxycholic Acid (NCT04407650)
- 2026-10-21Phase 3 first posted: Elsan, Colchicine + Amiodarone (NCT07887022)
- 2026-10-20Results posted on the registry: University of Hawaii, Metformin (NCT04500678)
- 2026-10-20Also stopped (terminated): University of Hawaii, Metformin (NCT04500678)
- 2026-10-06Results posted on the registry: University of Michigan, Metformin (NCT04625946)
- 2026-09-25Phase 3 first posted: Fondazione IRCCS Policlinico San Matteo di Pavia, L-PSGB first (NCT07841080)
- 2026-09-21Results posted on the registry: Barts & The London NHS Trust, Medical treatment alone (NCT01411371)
- 2026-09-18Also stopped (terminated): Gilead Sciences, MBX-102 + Placebo (NCT00814372)
- 2026-09-14Results posted on the registry: VA Office of Research and Development, Metformin Hydrochloride + Placebo (NCT04221750)
- 2026-09-11Phase 3 first posted: Tanta University, Empagliflozin (EMPA) + Metformin (NCT07815808)
- 2026-09-10Also stopped (terminated): CAMC Health System, Metoprolol + Diltiazem (NCT02025465)
- 2026-09-09Phase 3 first posted: Tanta University, Metformin + Vildagliptin (Galvus) (NCT07811011)
- 2026-09-09Phase 3 first posted: Tanta University, Metformin + Dapagliflozin (10mg Tab) (NCT07810998)
- 2026-09-08Also stopped (withdrawn): Eli Lilly and Company, LY3526318 + Placebo (NCT05580250)
- 2026-09-02Results posted on the registry: University of Arizona, Extended Release Metformin Hydrochloride + Placebo Administration (NCT05237960)
- 2026-08-31Results posted on the registry: Emory University, Oral Anti-diabetes Drugs alone + Basal bolus insulin (NCT04416269)
- 2026-08-31Also stopped (terminated): Emory University, Oral Anti-diabetes Drugs alone + Basal bolus insulin (NCT04416269)
- 2026-08-27Also stopped (terminated): James Wang, Metformin + Placebo (NCT06100822)
- 2026-08-24Results posted on the registry: Northwestern University, Metformin + Placebo (NCT03054519)
- 2026-08-06Results posted on the registry: University of Massachusetts, Worcester, Isoniazid + Rifampicin (NCT04930744)
- 2026-07-31Results posted on the registry: Massachusetts General Hospital, Morphine + Guanfacine 1mg (NCT01681264)
- 2026-07-31Also stopped (terminated): Massachusetts General Hospital, Morphine + Guanfacine 1mg (NCT01681264)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision